Perineuraxial Anesthesia Fluid Management and Infant Neurobehaviors (PAFUMIN)

July 26, 2011 updated by: Nanjing Medical University

Correlation Between Perineuraxial Anesthesia Fluid Resuscitation in Cesarean Section and Infant Neurobehaviors

Early change in neurobehavior is strongly associated with the intelligence development of children. Previous studies reported that cesarean section itself could influence the later development of children. In addition, neuraxial anesthesia including epidural, spinal and combined spinal epidural anesthesia (CSEA) are the major forms used during cesarean delivery, and these anesthesia techniques will undoubtedly evoke hypotension and corresponding hemodynamic alteration, of which would result in decreasing in umbilical placental insufficiency and fetus hypoxia leading to early abnormality of neurobehaviors in infants. Fluid management, such as crystalloid and colloid, is the common ones given before or / and after neuraxial anesthesia to prevent or reverse hypotension. However, it is still unknown whether the perineuraxial anesthesia fluid resuscitation could improve the neurobehavior scorings, and could produce positive effect on later intelligence development. Herein the investigators hypothesized that effective perineuraxial anesthesia fluid management during cesarean section would prevent the occurrence of hypotension and improve infant's neurobehavior scorings.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

5000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Nanjing, Jiangsu, China, 210004
        • The Affiliated Nanjing Maternity and Child Health Care Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 21-40 yr
  • First time of delivery
  • ASA status I-II
  • No premature
  • No genetic and infectious diseases
  • Chinese

Exclusion Criteria:

  • < 21 yr
  • > 40 yr
  • Subjects with cardiac and pulmonary disorders
  • Dislocation of placenta
  • Pregnant hypertension
  • Allergy to local anesthetics
  • Unwilling to cooperation
  • With significant delivery side effects

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Crystalloid resuscitation
Crystalloid (Ringer's lactate) will be delivered before (15min) or after (15min) neuraxial anesthesia
Ringer's Lactate 8 ml/kg was given intravenously before or after epidural, spinal or CSEA in cesarean section
Other Names:
  • Lactated Ringer's solution
ACTIVE_COMPARATOR: Colloid resuscitation
Colloid (6% hydroxyethyl starch ) will be delivered before (15min) or after (15min) neuraxial anesthesia
Hydroxyethyl starch (6%) was given before or after epidural, spinal or CSEA in cesarean section
Other Names:
  • HES/HAES

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: Immediate after birth (0 min)
Immediate after birth (0 min)

Secondary Outcome Measures

Outcome Measure
Time Frame
Apgar scoring
Time Frame: One min and 5min after birth.
One min and 5min after birth.
Umbilical-cord gases analysis
Time Frame: At the time baby was born (0min)
At the time baby was born (0min)
Neonatal sepsis evaluation
Time Frame: One hour after the baby was born
One hour after the baby was born
Neonatal antibiotic treatment
Time Frame: One hour after the baby was born
One hour after the baby was born
Incidence of maternal side effects
Time Frame: Analgesia initiation (0min) to successful vaginal delivery (this time encountered alteration with different women)
Analgesia initiation (0min) to successful vaginal delivery (this time encountered alteration with different women)
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 30min after birth
30min after birth
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 1h after birth
1h after birth
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 8h after birth
8h after birth
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 1d after birth
1d after birth
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 1wk after birth
1wk after birth
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 1month after birth
1month after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (ACTUAL)

May 1, 2011

Study Completion (ACTUAL)

May 1, 2011

Study Registration Dates

First Submitted

September 30, 2009

First Submitted That Met QC Criteria

September 30, 2009

First Posted (ESTIMATE)

October 1, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

July 27, 2011

Last Update Submitted That Met QC Criteria

July 26, 2011

Last Verified

July 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • NJMU-0932MZ
  • NMUK2190

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section

Clinical Trials on Ringer's Lactate

3
Subscribe